Kyrgyzstan and Pakistan strengthen cooperation in drug regulation

Kyrgyzstan and Pakistan have signed a memorandum of understanding to enhance their collaboration in the critical area of drug regulation. The agreement, inked between Kyrgyzstan's Ministry of Health and Pakistan's Drug Regulatory Authority (DRAP), signals a commitment to bolstering bilateral ties in healthcare.

The memorandum is designed to foster a more robust exchange of regulatory information and practical experience between the two nations. It also paves the way for joint training initiatives aimed at strengthening pharmacovigilance systems, which are crucial for monitoring the safety of medicines. Furthermore, the pact includes provisions for capacity building and collaborative efforts in inspecting and ensuring the quality of medical products, aligning them with international standards.

Officials view this memorandum as a significant step forward in developing a stronger partnership between Kyrgyzstan and Pakistan within the health sector. By improving the regulatory frameworks for medicines and medical devices, the agreement is expected to ultimately benefit the citizens of both countries, ensuring greater access to safe and effective healthcare products.